Pharmacological evaluation of combination therapy of P388 leukemia with cyclophosphamide and pyrimidinones.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D007694:Killer Cells, Natural / Q000187:drug effects; D007941:Leukemia P388 / Q000188:drug therapy*; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D011744:Pyrimidinones / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011744:Pyrimidinones; D003520:Cyclophosphamide